Karafin MS - Search Results

1

Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.

Karafin MS, Bruhn R, Westlake M, Sullivan MT, Bialkowski W, Edgren G, Roubinian NH, Hauser RG, Kor DJ, Fleischmann D, Gottschall JL, Murphy EL, Triulzi DJ; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Karafin MS, et al. Transfusion. 2017 Dec;57(12):2903-2913. doi: 10.1111/trf.14370. Epub 2017 Oct 24. Transfusion. 2017. PMID: 29067705 Free PMC article.

2

The impact of apheresis platelet manipulation on corrected count increment.

Karafin M, Fuller AK, Savage WJ, King KE, Ness PM, Tobian AA. Karafin M, et al. Transfusion. 2012 Jun;52(6):1221-7. doi: 10.1111/j.1537-2995.2011.03476.x. Epub 2012 Jan 10. Transfusion. 2012. PMID: 22233358 Free PMC article.

3

ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.

Karafin MS, Blagg L, Tobian AA, King KE, Ness PM, Savage WJ. Karafin MS, et al. Transfusion. 2012 Oct;52(10):2087-93. doi: 10.1111/j.1537-2995.2012.03574.x. Epub 2012 Feb 17. Transfusion. 2012. PMID: 22339320 Free PMC article.

4

Transfusion medicine education: an integral foundation of effective blood management.

Karafin MS, Bryant BJ. Karafin MS, et al. Transfusion. 2014 May;54(5):1208-11. doi: 10.1111/trf.12658. Transfusion. 2014. PMID: 24819073 No abstract available.

5

The future of red blood cell alloimmunization risk reduction.

Karafin MS, Denomme GA, Bryant BJ. Karafin MS, et al. Transfusion. 2015 Jan;55(1):220-1. doi: 10.1111/trf.12863. Transfusion. 2015. PMID: 25582238 No abstract available.

6

Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

Karafin MS, Field JJ, Gottschall JL, Denomme GA. Karafin MS, et al. Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9. Transfusion. 2015. PMID: 25757390

7

Red cell storage age policy for patients with sickle cell disease: A survey of transfusion service directors in the United States.

Karafin MS, Singavi AK, Irani MS, Puca KE, Baumann Kreuziger L, Simpson P, Field JJ. Karafin MS, et al. Transfus Apher Sci. 2016 Feb;54(1):158-62. doi: 10.1016/j.transci.2015.12.001. Epub 2015 Dec 23. Transfus Apher Sci. 2016. PMID: 26775259

8

Clinical and reference lab characteristics of patients with suspected direct antiglobulin test (DAT)-negative immune hemolytic anemia.

Karafin MS, Denomme GA, Schanen M, Gottschall JL. Karafin MS, et al. Immunohematology. 2015;31(3):108-15. Immunohematology. 2015. PMID: 26829176

9

Phosphatidylethanolamine is progressively exposed in RBCs during storage.

Larson MC, Karafin MS, Hillery CA, Hogg N. Larson MC, et al. Among authors: karafin ms. Transfus Med. 2017 Apr;27(2):136-141. doi: 10.1111/tme.12382. Epub 2017 Jan 30. Transfus Med. 2017. PMID: 28134466 Free PMC article.

10

Trends in US minority red blood cell unit donations.

Yazer MH, Delaney M, Germain M, Karafin MS, Sayers M, Vassallo R, Ziman A, Shaz B; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Yazer MH, et al. Among authors: karafin ms. Transfusion. 2017 May;57(5):1226-1234. doi: 10.1111/trf.14039. Epub 2017 Feb 16. Transfusion. 2017. PMID: 28205236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page